[Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].

CONCLUSION: More in-depth knowledge is required for many sarcomas to link their genetic alterations to tumorigenesis in order to develop efficient personalised treatment strategies. Clinical trial designs need to be adapted to evaluate new therapeutic strategies in these ultra-rare tumours and their various sub-types more efficaciously. PMID: 31396640 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31396640?dopt=Abstract

Source: Der Orthopade - August 7, 2019 Category: Orthopaedics Authors: Scheipl S, Liegl-Atzwanger B, Szkandera J, Rinner B, Viertler C, Friesenbichler J, Bergovec M, Leithner A Tags: Orthopade Source Type: research